Remus Pharmaceuticals Ltd.
Issue Open Date 17-May-23  
Issue Closing Date 19-May-23  
Application Money 100  
Allotment Money  
Price Band () 1150 - 1229  
Minimum Bid Quantity. 100  
Issue Size (Shares) 388000  
Market Lot 1  
Objective

1. To Meet Working Capital Requirements.2. Funding investments for acquisitions and general corporate purposes.3. To meet Public Issue Expenses.

Business Description

Our company is engaged in marketing & distribution of finished formulations of pharmaceutical drugs. Our company alsodeals in API (Active Pharmaceutical Ingredient). We also provide technical consultancy services to various distributors forpreparation of reports on the dossiers of the products to be registered by them in various countries.Having cultivated strong and dependable customer relatio...

Promoter's Holding
Total Share Capital   1007125  
Offered to Public   388000  
Promoter's Holding (Pre-Issue)   92.82  
Promoter's Holding (Post-Issue)   68.37  
Address
Address :1101 To 1103
South Tower
One 42
B/h Ashok Vatika
Nr. Jayantilal Park
Brts
Ambli Bopal Road
City :Ahmedabad, State :Gujarat Pincode :380054 Phone :079-29999857 Email : cs@remuspharma.com Website : www.remuspharma.com
Registrar
Link Intime India Pvt Ltd.
C 101
247 Park
LBS Marg
Vikhroli (West)
Mumbai
Listed at
NSE
Lead Manager
Beeline Capital Advisors Pvt Ltd.
Promoters
Anar Swapnil Shah
Arpit Deepakkumar Shah
Roma Vinodbhai Shah
Swapnil Jatinbhai Shah

© 2019. MSE Financial Services Ltd. All Rights Reserved

Developed & Content Powered by  Accord Fintech Pvt. Ltd.